Self-Assembling Porphyrins as a Single Therapeutic Agent for Synergistic Cancer Therapy: A One Stone Three Birds Strategy
Jun Chen,Feng Chen,Lei Zhang,Zhangyou Yang,Tao Deng,Yunfei Zhao,Tianye Zheng,Xuelan Gan,Hangtian Zhong,Yanqing Geng,Xinwei Fu,Yuanqiang Wang,Chao Yu
DOI: https://doi.org/10.1021/acsami.1c04868
2021-06-10
Abstract:Combining photodynamic therapy (PDT), chemodynamic therapy (CDT), and ferroptosis is a valuable means for an enhanced anticancer effect. However, traditional combination of PDT/CDT/ferroptosis faces several hurdles, including excess glutathione (GSH) neutralization and preparation complexity. In this work, a versatile multifunctional nanoparticle (HCNP) self-assembled from two porphyrin molecules, chlorin e6 and hemin, is developed. The as-constructed HCNPs exhibit a peroxidase-mimic catalytic activity, which can lead to the in situ generation of endogenous O<sub>2</sub>, thereby enhancing the efficacy of PDT. Furthermore, the generation of hydroxyl radicals (<sup>•</sup>OH) in the tumor environment in reaction to the high level of H<sub>2</sub>O<sub>2</sub> and the simultaneous disruption of intracellular GSH endow the HCNPs with the capacity of enhanced CDT, resulting in a more effective therapeutic outcome in combination with PDT. More importantly, GSH depletion further leads to the inactivation of GSH peroxide 4 and induced ferroptosis. Both in vitro and in vivo results showed that the combination of PDT/CDT/ferroptosis realizes highest antitumor efficacy significantly under laser irradiation. Therefore, by integrating the superiorities of O<sub>2</sub> and <sup>•</sup>OH generation capacity, GSH-depletion effect, and bioimaging into a single nanosystem, the HCNPs are a promising single therapeutic agent for tumor PDT/CDT/ferroptosis combination therapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c04868?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c04868</a>.DLS size profile of HCNPs with different precursor molar concentration ratios; ζ potential and XPS spectra of HCNPs; fluorescence spectra of free Ce6 and HCNPs in different media; the photostability of HCNPs; UV–vis absorption spectra of MB degradation by different concentrations of hemin; photographs of HCNP solutions with H<sub>2</sub>O<sub>2</sub>; <sup>1</sup>O<sub>2</sub> generation of HCNPs with or without H<sub>2</sub>O<sub>2</sub>; photothermal effect of HCNPs; the detection of Fe<sup>2+</sup> of HCNPs with different concentrations of GSH; DLS size profile of HCNPs after incubation with 10 mM GSH; stability of HCNPs; MD simulation; the UV spectrum of HCNPs in different buffer solutions; the cell uptake and intracellular location of HCNPs; Western blot analysis of GPX4 in 4T1 cells after treatment with PBS, Ce6, and hemin; determination of ROS in 4T1 cells by flow cytometry analysis; live/dead cell assay for cells treated with PBS, Ce6, hemin, and HCNPs in different conditions; cell viability of 4T1 cells treated with different concentrations of Ce6 or hemin; schematic illustration of the self-enhanced PDT/CDT and GSH-depletion triggered ferroptosis effect; fluorescent intensity of HCNPs in excised tumor and major healthy organs; digital images of 4T1-tumor-bearing mice at different administration time points; photographs of tumors taken from different groups of mice; H&E staining images of major organs; digital image of hemolysis; blood biochemistry analysis (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c04868/suppl_file/am1c04868_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology